Here are five updates on GI companies from the past week:
The FDA granted TiGenix orphan drug designation for Cx601, its lead candidate which treats fistulizing Crohn's disease.
Apollo Endosurgery entered into a registry funding agreement with the American Gastroenterological Association to develop a flexible endoscopic procedures registry.
Ambu acquired Invendo Medical and its single-use endoscope business for €225 million ($265 million.)
The UK Medicines and Healthcare Products Regulatory Agency approved Norgine B.V.'s bowel cleaning solution Plenvu.